About electroCore, Inc
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Rockaway, New Jersey. Address: 200 Forge Way, Rockaway, NJ, United States, 07866
electroCore, Inc News and around…
Latest news about electroCore, Inc (ECOR) common stock and company :
ROCKAWAY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third quarter ended September 30, 2021 after the close of the market on Thursday, November 4, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions. Thursday, November 4, 2021, 4:30pm Eastern TimeDomestic: 877-269-7756International
ROCKAWAY, NJ, Oct. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper entitled “Non-invasive vagus nerve stimulation for treatment of cluster headache: a retrospective review of prescribing in England,” in the British Journal of Healthcare Management. The paper reviews the prescribing trends of gammaCore in England from April 2019 through the end of 2020. gammaCore was listed o
Health Canada expands gammaCore label to include the acute and preventive treatment of migraine in adolescentsROCKAWAY, NJ, Oct. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that the company received an amended Medical Device License from Health Canada to expand the label of gammaCore nVNS to include the acute and preventive treatment of migraine in adolescents between 12 and 17 years of age. gammaCore is now cl
Third quarter 2021 revenue expected to be approximately $1.5 millionNet cash used to fund operations in the third quarter 2021 of approximately $3.5 million ROCKAWAY, NJ, Oct. 12, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as select unaudited preliminary financial guidance for the third quarter of 2021. “We are pleased to announce preliminary third quarter results, which con
ROCKAWAY, NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced the granting of the company’s motion to dismiss the federal court securities class action case filed in Trenton, NJ. On August 13, 2021, New Jersey Federal District Court Judge Anne E. Thompson dismissed the investors' complaint alleging that statements made in the registration statement for the company’s initial public offering in 2018, and public statem
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th \- 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The Fall Harvest - Best Ideas from the Buy Side: VIRTUAL begins on Tuesday, October 5th, 2021, with company presentations beginning at 8:30 am Eastern Time.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks have a place in every portfolio when adjusted for risk. These 7 have the added safety of a Nasdaq listing. The post 7 Best Penny Stocks to Buy on the Nasdaq for October appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar
Gainers Geovax Labs (NASDAQ:GOVX) shares rose 46.37% to $6.06 during Tuesday's after-market session. This security traded at a ...
Gainers eFFECTOR Therapeutics (NASDAQ:EFTR) stock rose 4.43% to $17.91 during Friday's after-market session. The ...
Every investor wants to find the best market returns, and they’ll follow a variety of strategies to get there. One common strategy – and one that offers plenty of promise for investors who don’t mind shouldering the extra risk – is to go after penny stocks. Traditionally seen as stocks priced for just pennies per share, these equities are now defined as those with a share price of $5 or less. For the tough-minded investors, these low-cost stocks present a combination of risk/reward that few othe
ROCKAWAY, NJ, Sept. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Board of Directors has appointed Peter Cuneo as Chairman of the Board of Directors effective October 1, 2021. Mr. Cuneo was appointed to the Board of Directors in April 2020. He succeeds Mike Atieh, who served as Chairman since April 2020 and who will remain on the Board as an independent director and member of the audit committee. Over th
ROCKAWAY, NJ, Aug. 31, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation at the HC Wainwright 23rd Annual Global Investment Conference. The conference is taking place virtually from September 13 - 15, 2021. Details for the presentation are as follows: HC Wainwright 23rd Annual Global Investment Conference:Date: Monday, September 13, 2021Time: th
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
By John Vandermosten, CFA NASDAQ:ECOR READ THE FULL ECOR RESEARCH REPORT Second Quarter 2021 Financial and Operational Results On August 5, 2021, electroCore Inc. (NASDAQ:ECOR) presented its second quarter 2021 financial and operational results in a press release and Form 10-Q filed with the SEC. A conference call with investors and analysts was held concurrent with the release. Revenues
Second quarter 2021 net sales of $1.3 million, increased 69% over second quarter 2020 and 5% sequentially. Company to host a conference call and webcast today, August 5, 2021 at 4:30 pm ET
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We're halfway through the week and still going strong with a look at the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now.
A combination of a large total addressable market, regulatory clearance, strong partnershipsand effective product has Ladenburg ...
Ladenburg Thalmannhas initiated coverageofElectroCore Inc(NASDAQ: ECOR) with a Buy rating and $3 price ...